Cargando…
THU050 The Role Of The GH Receptor Polymorphism As Prognostic Factor Of Vertebral Fractures In Acromegaly Patients Resistant To First Generation SSAs And Treated With GH Receptor Antagonist Or Second Generation Somatostatin Ligand
Disclosure: F. Costanza: None. S. Chiloiro: None. A. Giampietro: None. P. Mattogno: None. A. Infante: None. F. Angelini: None. L. Lauretti: None. A. Olivi: None. A. Pontecorvi: None. F. Doglietto: None. L. De Marinis: None. A. Bianchi: None. Acromegaly is associated with skeletal fragility and an in...
Autores principales: | Costanza, Flavia, Chiloiro, Sabrina, Giampietro, Antonella, Mattogno, Pierpaolo, Infante, Amato, Angelini, Flavia, Lauretti, Liverana, Olivi, Alessandro, Pontecorvi, Alfredo, Doglietto, Francesco, De Marinis, Laura, Bianchi, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553751/ http://dx.doi.org/10.1210/jendso/bvad114.1130 |
Ejemplares similares
-
THU055 The Acro-TIME Score: A New Clinical, Pathological And Immune Integrative Approach To Early Identify Acromegaly Patients Resistant To Treatment With First Generation Somatostatin Ligands
por: Chiloiro, Sabrina, et al.
Publicado: (2023) -
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors
por: Mattogno, Pier Paolo, et al.
Publicado: (2021) -
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study
por: Bima, Chiara, et al.
Publicado: (2021) -
MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar
por: Chiloiro, Sabrina, et al.
Publicado: (2020) -
THU483 Role Of Excess GH On Breast Cancer Aggressiveness And Metastasis In Acromegaly
por: Hun, Ju, et al.
Publicado: (2023)